Wen et al. (2016) demonstrated that solanine treatment suppresses vascular endothelial growth factor expression in human pancreatic cancer cells by down-regulating the ERK1/2-HIF-1α and STAT3 signaling pathways [38]. This evidence concerns the gene MAPK3 and familial pancreatic carcinoma.